ALFA FinderNSE filing, NSE: EXICOM. Summary written from the filing by ALFA Finder's alert engine.
Exicom Tele-Systems Ltd: key numbers
- Share price
- ₹136.98
- Market cap
- ₹1,906 Cr
- Revenue (annual)
- ₹1,152 Cr
- Net profit (annual)
- ₹-274.1 Cr
- P/E (TTM)
- -14.3×Sector 21.9×
- Promoter holding
- 65.20%+0.00% QoQ
- FII holding
- 0.97%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Exicom Tele-Systems Ltd
All →Exicom Tele-Systems Annual General Meeting
Exicom seeks shareholder approval via postal ballot to divest its Tritium business at an indicative ₹799 Crore (USD 85 million) value. E-voting closes 6 December 2026.
- Value
- ₹799.0 Cr
Exicom Tele-Systems Business Update
Exicom Tele-Systems is consolidating manufacturing by transitioning operations from its Gurugram facility to existing plants in Hyderabad and Solan. The transition aims to optimize infrastructure and is expected to finish by November 15, 2026.
- Execution
- November 15, 2026
Exicom Tele-Systems Merger & Restructuring Worth ₹799 Cr
Exicom Tele-Systems Limited reported a 38% sequential rise in consolidated revenue to ₹388.3 crore for Q2 FY27. The Board also approved the divestment of Tritium for USD 85 million.
- Value
- ₹799.0 Cr
Exicom Tele-Systems Q2 FY27 Results: Net Loss of ₹56.8 Cr, Loss Narrows
Exicom Tele-Systems Ltd reported revenue from operations of ₹388.3 Cr (+37.8% YoY) and a net loss of ₹56.8 Cr for Q2 FY27.
- Key figure
- Net loss ₹56.8 Cr
Exicom Tele-Systems Board Meeting Date
Exicom Tele-Systems will hold a board meeting on November 4, 2026 to consider Q2 and half-year unaudited results. The trading window will reopen on November 7, 2026.
Exicom Tele-Systems Other Announcement
Exicom Tele-Systems Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended September 30, 2026.
Other product launch announcements
All →AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.
Puravankara Product Launch
Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.
JBM Auto Product Launch
JBM Electric Vehicles launched the all-electric ECOLIFE e12 city bus at Singapore Urban Mobility Week 2026. It cites 20,000-bus annual capacity and a new Singapore APAC hub.
- electric bus manufacturing capacity
- 20000.0 buses per annum
Restaurant Brands Asia Product Launch
Burger King India launches a limited-edition Avengers: Doomsday Collection across nationwide restaurants. The menu features themed burgers, sides, and merchandise starting at ₹199.
Hero MotoCorp Product Launch
Hero MotoCorp unveiled new motorcycles at EICMA 2026 and started VIDA customer deliveries across Europe. The company also introduced Novus Labs, its future-mobility innovation hub.